EE233 LONG-TERM OUTCOMES OF LENACAPAVIR PLUS OPTIMIZED BACKGROUND REGIMEN VERSUS OTHER TREATMENTS FOR MULTI-DRUG RESISTANT HIV VIA A COST-EFFECTIVENESS MODEL
Abstract
Authors
V Vardanega W Rawlinson S Francis-Graham D Mezzio LA Eddowes